Related references
Note: Only part of the references are listed.Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1
Wenbin Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer
M. Kioulafa et al.
ANNALS OF ONCOLOGY (2009)
Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3)
Roger S. Kirby et al.
BJU INTERNATIONAL (2009)
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
M. Talieri et al.
BRITISH JOURNAL OF CANCER (2009)
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma
N. M. A. White et al.
BRITISH JOURNAL OF CANCER (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
A Tumor-Protective Role for Human Kallikrein-Related Peptidase 6 in Breast Cancer Mediated by Inhibition of Epithelial-to-Mesenchymal Transition
Georgios Pampalakis et al.
CANCER RESEARCH (2009)
Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies
Xiaoqing Li et al.
CANCER SCIENCE (2009)
The footprints of cancer development: Cancer biomarkers
Mohd. Fahad Ullah et al.
CANCER TREATMENT REVIEWS (2009)
Quantitative Analysis of Human Kallikrein 5 (KLK5) Expression in Prostate Needle Biopsies: An Independent Cancer Biomarker
Dimitrios Korbakis et al.
CLINICAL CHEMISTRY (2009)
Functional Roles of Human Kallikrein-related Peptidases
Georgia Sotiropoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Differential N-glycosylation of Kallikrein 6 Derived from Ovarian Cancer Cells or the Central Nervous System
Uros Kuzmanov et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Prostate kallikrein markers in diagnosis, risk stratification and prognosis
David Ulmert et al.
NATURE REVIEWS UROLOGY (2009)
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression
A. Psyrri et al.
ANNALS OF ONCOLOGY (2008)
Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung
Chris Planque et al.
BIOLOGICAL CHEMISTRY (2008)
microRNAs: a new frontier in kallikrein research
George M. Yousef
BIOLOGICAL CHEMISTRY (2008)
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells
Rebecca S. Henkhaus et al.
BIOLOGICAL CHEMISTRY (2008)
Localized prostate cancer: can we better define who is at risk of unfavourable outcome?
Steven Joniau et al.
BJU INTERNATIONAL (2008)
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
F. Rueckert et al.
BRITISH JOURNAL OF CANCER (2008)
Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
K. Oikonomopoulou et al.
BRITISH JOURNAL OF CANCER (2008)
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA)
Panteieimon Kountourakis et al.
CANCER SCIENCE (2008)
Kallikrein-related peptidases
A. Lundwall et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma
Chris Planque et al.
CLINICAL CANCER RESEARCH (2008)
Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
Girish Sardana et al.
CLINICAL CHEMISTRY (2008)
Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases
Kristina Stefansson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer
Jane Bayani et al.
MOLECULAR ONCOLOGY (2008)
High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse
Anja Rabien et al.
TUMOR BIOLOGY (2008)
New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family
Nashmil Emami et al.
MOLECULAR ONCOLOGY (2007)
A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy
Yingye Zheng et al.
CLINICAL CANCER RESEARCH (2007)
hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml
Rene Raaijmakers et al.
EUROPEAN UROLOGY (2007)
Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion
Britta Klucky et al.
CANCER RESEARCH (2007)
Distribution of 15 human kallikreins in tissues and biological fluids
Julie L. V. Shaw et al.
CLINICAL CHEMISTRY (2007)
Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells
Yasuo Shinoda et al.
CANCER SCIENCE (2007)
Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer
Tove Irene Klokk et al.
CANCER RESEARCH (2007)
Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin
Sarah K. Johnson et al.
CANCER (2007)
Human tissue kallikreins: The cancer biomarker family
Miltiadis Paliouras et al.
CANCER LETTERS (2007)
Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer
Jin Gao et al.
PROSTATE (2007)
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer
Thomas Steuber et al.
CLINICAL CHEMISTRY (2007)
Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects
S. J. C. Shan et al.
BRITISH JOURNAL OF CANCER (2007)
Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14
Carla A. Borgono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness
Yuh-Pyng Sher et al.
CANCER RESEARCH (2006)
The discovery of prostate specific antigen as a biomarker for the early detection of adenocarcinoma of the prostate
Danil V. Makarov et al.
JOURNAL OF UROLOGY (2006)
Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols
Shannon J. C. Shan et al.
CLINICAL CHEMISTRY (2006)
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer
Bo Feng et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Decreased kallikrein 11 messenger RNA expression in lung cancer
Hidefumi Sasaki et al.
CLINICAL LUNG CANCER (2006)
The kallikrein world: an update on the human tissue kallikreins
Miltiadis Paliouras et al.
BIOLOGICAL CHEMISTRY (2006)
Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikre-in 7:: Prognostic relevance of KLK7 mRNA expression in breast cancer
Leon Holzscheiter et al.
CLINICAL CHEMISTRY (2006)
Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer
C Stephan et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer
CA Borgoño et al.
CLINICAL CANCER RESEARCH (2006)
Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status
F Fritzsche et al.
BRITISH JOURNAL OF CANCER (2006)
Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma
CD Petraki et al.
TUMOR BIOLOGY (2006)
Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer
H Nagahara et al.
CLINICAL CANCER RESEARCH (2005)
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells
TL Veveris-Lowe et al.
ENDOCRINE-RELATED CANCER (2005)
Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer
P Stavropoulou et al.
CLINICA CHIMICA ACTA (2005)
Human tissue kallikrein gene family: applications in cancer
CV Obiezu et al.
CANCER LETTERS (2005)
Human kallikrein 6: A new potential serum biomarker for uterine serous papillary cancer
AD Santin et al.
CLINICAL CANCER RESEARCH (2005)
Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer
K Ogawa et al.
CLINICAL CANCER RESEARCH (2005)
Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression
IP Michael et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries
M Matsumura et al.
PROSTATE (2005)
Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer
K Shigemasa et al.
CLINICAL CANCER RESEARCH (2004)
Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer
ZJ Xi et al.
CANCER RESEARCH (2004)
Human kallikrein 13 protein in ovarian cancer cytosols:: A new favorable prognostic marker
A Scorilas et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The normal epithelial cell-specific 1 (NES1) gene, a candidate tumor suppressor gene on chromosome 19q13.3-4, is downregulated by hypermethylation in acute lymphoblastic leukemia
J Roman-Gomez et al.
LEUKEMIA (2004)
Human kallikrein 11:: an indicator of favorable prognosis in ovarian cancer patients
EP Diamandis et al.
CLINICAL BIOCHEMISTRY (2004)
The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells
AD Santin et al.
GYNECOLOGIC ONCOLOGY (2004)
Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer
ZJ Xi et al.
GYNECOLOGIC ONCOLOGY (2004)
The emerging roles of human tissue kallikreins in cancer
CA Borgoño et al.
NATURE REVIEWS CANCER (2004)
Human kallikrein 13 involvement in extracellular matrix degradation
C Kapadia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Favorable prognostic value of tissue human kallikrein 11 (hk11) in patients with ovarian carcinoma
CA Borgoño et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues
GM Yousef et al.
PROSTATE (2003)
Prognostic value of the human kallikrein gene 15 expression in ovarian cancer
GM Yousef et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery
MJ Yunes et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Human and mouse proteases:: A comparative genomic approach
XS Puente et al.
NATURE REVIEWS GENETICS (2003)
Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues
T Nakamura et al.
UROLOGY (2003)
Human kallikrein 6 (hK6): A new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma
EP Diamandis et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer
GM Yousef et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer
GM Yousef et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
LG Kyriakopoulou et al.
CLINICAL BIOCHEMISTRY (2003)
Quantitative analysis of kallikrein 15 gene expression in prostate tissue
C Stephan et al.
JOURNAL OF UROLOGY (2003)
Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis
EP Diamandis et al.
TUMOR BIOLOGY (2003)
Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
GM Yousef et al.
BRITISH JOURNAL OF CANCER (2002)
The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
GM Yousef et al.
BRITISH JOURNAL OF CANCER (2002)
Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient sera
CH Day et al.
ONCOGENE (2002)
Differential expression of kallikrein gene 5 in cancerous and normal testicular tissues
GM Yousef et al.
UROLOGY (2002)
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker
BR Hoffman et al.
BRITISH JOURNAL OF CANCER (2002)
Human tissue kallikreins: A new enzymatic cascade pathway?
GM Yousef et al.
BIOLOGICAL CHEMISTRY (2002)
Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance
LY Luo et al.
BRITISH JOURNAL OF CANCER (2002)
Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer
A Chang et al.
BRITISH JOURNAL OF CANCER (2002)
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
GM Yousef et al.
PROSTATE (2002)
Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast,testicular, and ovarian cancers
BB Bharaj et al.
PROSTATE (2002)
Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue
LY Luo et al.
BRITISH JOURNAL OF CANCER (2001)
The new human tissue kallikrein gene family: Structure, function, and association to disease
GM Yousef et al.
ENDOCRINE REVIEWS (2001)
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
H Kim et al.
BRITISH JOURNAL OF CANCER (2001)
Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR
TK Takayama et al.
BIOCHEMISTRY (2001)
Molecular cloning of the human kallikrein 15 gene (KLK15) -: Up-regulation in prostate cancer
GM Yousef et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Increased expression of protease M in ovarian tumors
H Tanimoto et al.
TUMOR BIOLOGY (2001)
KLK12 is a novel serine protease and a new member of the human kallikrein gene family - Differential expression in breast cancer
GM Yousef et al.
GENOMICS (2000)
Human kallikrein 6 (zyme/protease M/neurosin): A new serum biomarker of ovarian carcinoma
EP Diamandis et al.
CLINICAL BIOCHEMISTRY (2000)
Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4
GM Yousef et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family -: genomic characterization, mapping, tissue expression and hormonal regulation
GM Yousef et al.
GENE (2000)
Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues
GM Yousef et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The expanded human kallikrein gene family: Locus characterization and molecular cloning of a new member, KLK-L3 (KLK9)
GM Yousef et al.
GENOMICS (2000)
Genomic organization, mapping. tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family
GM Yousef et al.
GENOMICS (2000)
Share Paper
